Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
Xiangyuan Luo(Tongji Hospital), Xingxing He(Nanchang University)
Cited by 216
Related Papers
YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition
|Experimental Hematology and Oncology|2021|101
Autophagy inhibition enhanced 5‑FU‑induced cell death in human gastric carcinoma BGC‑823 cells
|Molecular Medicine Reports|2018|22